NitroMed Home page
NitroMed BiDil Technology News: Press Releases Investors Careers
Shirley Ford: TAKING THE POTENTIAL OF NITRIC OXIDE TO HEART
FDA Approves BiDil
for the Treatment of Heart Failure in Black Patients


Click Here for Full Prescribing Information

Microphone Q4 2007 Nitromed, Inc. Earnings Conference Call
February 14 , 2008
9:00 AM EST
 Click here for webcast

5/7/2008
NitroMed Reports Financial Results for First Fiscal Quarter 2008


4/30/2008
NitroMed to Report Financial Results for First Fiscal Quarter 2008


3/28/2008
James G. Ham Resigns from NitroMed

Letter To Shareholders

  Link to NitroMed's letter to shareholders
           
Privacy Policy | Legal Notice | MSDS
Copyright © 2007 NitroMed, Inc. All Rights Reserved.

All rights reserved. This website contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding NitroMed's future financial position, business strategy, and plans and objectives of management for future operations. We may, in some cases, use words such as "believes," "expects," "anticipates," "plans," "estimates," and similar expressions to identify these forward-looking statements. There are a number of important factors that could cause NitroMed's actual results to differ materially from these indicated by such forward-looking statements, including those risk factors identified in the filings that NitroMed makes from time to time with the Securities and Exchange Commission. NitroMed disclaims any intention or obligation to update any forward-looking statements as a result of developments occurring after the date such statement was first made.

NitroMed does not review or control the content of non-NitroMed web sites and this hyperlink does not constitute an endorsement by NitroMed of the site's content. NitroMed's Terms and Conditions and Privacy Policy do not apply to a non-NitroMed web site.

Contact Home Site Map Media Center